PROCEPT Biorobotics Corp. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by PROCEPT Biorobotics Corporation (PRCT) on January 4, 2022, covering events occurring on December 29 and December 31, 2021. The Company is an emerging growth company incorporated in Delaware, with principal executive offices in Redwood City, California.
Key Financial Metrics and Material Agreements
The filing details a material definitive agreement regarding a new lease but does not report period-over-period revenue, profit, cash flow, or margin data.
- New Lease Agreement: Entered into on December 31, 2021, for approximately 158,221 square feet in San Jose, California.
- Lease Term: Anticipated commencement on or before December 31, 2022, for an initial term of 122 months, with two five-year extension options.
- Rent Structure: Annual base rent of approximately $4.3 million in the first year, increasing to approximately $5.5 million in year 10.
- Tenant Improvement Allowance: The Landlord will provide an allowance of up to approximately $7.9 million for construction of tenant improvements.
- Debt and Liquidity: The filing text does not provide specific values for current debt levels, liquidity positions, or cash flow metrics.
Material Changes and Corporate Governance
Effective December 29, 2021, the Board of Directors increased its size from eight to nine members and appointed Mary Garrett as a new Class II director.
- Director Appointment: Mary Garrett, formerly of Hillrom Corporation and IBM Corporation, was appointed to serve until the 2023 Annual Meeting of Stockholders.
- Compensation: Ms. Garrett received a restricted stock unit award valued at $200,000. The award vests one-third on the first anniversary of appointment and the remaining two-thirds over the subsequent two years, subject to continued service.
- Operational Relocation: The Company intends to relocate operations to the new San Jose Facility by the end of its current Redwood City lease term.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, forward-looking revenue projections, or specific risk factor disclosures beyond the standard indemnification agreement for the new director. The primary operational outlook involves the transition to the new San Jose facility.
Key Facts for Investor Verification
- Verify the exact commencement date of the San Jose lease and the associated capital expenditure timeline for the $7.9 million tenant improvement allowance.
- Confirm the impact of the new lease obligations ($4.3M starting rent) on the Company's future cash flow and liquidity in the upcoming 10-K filing.
- Review the full text of the indemnification agreement for Mary Garrett as referenced in the Company's Form S-1/A.
- Monitor the Company's progress in relocating operations from Redwood City to San Jose to ensure no disruption to business continuity.